M&A Deal Summary

Sunshine Biopharma Acquires Nora Pharma

On October 20, 2022, Sunshine Biopharma acquired life science company Nora Pharma for 300M CAD

Acquisition Highlights
  • This is Sunshine Biopharma’s 1st transaction in the Life Science sector.
  • This is Sunshine Biopharma’s largest (disclosed) transaction.
  • This is Sunshine Biopharma’s 1st transaction in Canada.
  • This is Sunshine Biopharma’s 1st transaction in Quebec.

M&A Deal Summary
Date 2022-10-20
Target Nora Pharma
Sector Life Science
Buyer(s) Sunshine Biopharma
Deal Type Add-on Acquisition
Deal Value 300M CAD

Target

Nora Pharma

Saint-Lambert, Quebec, Canada
Nora Pharma is a pharmaceutical company offering generic and specialty drugs. Nora Pharma is based in Saint-Lambert, Quebec.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sunshine Biopharma

Pointe-Claire, Quebec, Canada
Category Company
Sector Life Science
Employees44
Revenue 24M USD (2023)
DESCRIPTION

Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma is based in Pointe-Claire, Quebec.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal